Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma.

Joshi SR, Akat PB, Ramanand JB, Ramanand SJ, Karande VB, Jain SS.

Indian J Ophthalmol. 2013 Dec;61(12):765-7. doi: 10.4103/0301-4738.116456.

3.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

Arch Ophthalmol. 2006 Sep;124(9):1230-8.

PMID:
16966616
5.

The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.

Baiza-Durán LM, Alvarez-Delgado J, Contreras-Rubio AY, Medrano-Palafox J, De Luca-Brown A, Casab-Rueda H, Cortés-Gastélum MA, Garcidueñas-Mejía MJ, Gómez-Bastar P, Gil-Carrasco F, Hartleben-Matkin C, Jiménez-Román J, Moreno-Marín ML, Paczka-Zapata JA, Velasco-Gallegos G, Vergara-Sinta M.

Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):174-8.

PMID:
20214051
6.

Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.

Konstas AG, Holló G, Haidich AB, Mikropoulos DG, Giannopoulos T, Voudouragkaki IC, Paschalinou E, Konidaris V, Samples JR.

J Ocul Pharmacol Ther. 2013 Sep;29(7):652-7. doi: 10.1089/jop.2012.0195. Epub 2013 Apr 3.

PMID:
23550916
9.

Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Sharpe ED, Henry CJ, Mundorf TK, Day DG, Stewart JA, Jenkins JN, Stewart WC.

Eye (Lond). 2005 Jan;19(1):35-40.

PMID:
15094733
10.

Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.

Cho SW, Kim JM, Park KH, Choi CY.

Jpn J Ophthalmol. 2010 Sep;54(5):407-13. doi: 10.1007/s10384-010-0855-4. Epub 2010 Nov 5.

PMID:
21052902
11.
12.

Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.

Konstas AG, Katsimpris IE, Kaltsos K, Georgiadou I, Kordelou A, Nelson LA, Stewart WC.

Eye (Lond). 2008 Nov;22(11):1391-7. Epub 2007 Jun 15.

PMID:
17571086
13.

Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma.

Konstas AG, Quaranta L, Yan DB, Mikropoulos DG, Riva I, Gill NK, Barton K, Haidich AB.

Eye (Lond). 2012 Jan;26(1):80-7. doi: 10.1038/eye.2011.239. Epub 2011 Sep 30.

14.

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.

PMID:
12623832
15.

The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.

Yüksel N, Altintaş O, Karabaş L, Alp B, Cağlar Y.

Ophthalmologica. 1999;213(4):228-33.

PMID:
10420106
16.

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.

Konstas AG, Stewart WC, Topouzis F, Tersis I, Holmes KT, Stangos NT.

Am J Ophthalmol. 2001 Jun;131(6):729-33.

PMID:
11384568
17.
18.

Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.

Zabriskie N, Netland PA; Brimonidine with Latanoprost Study Groups 1 and 2.

Adv Ther. 2003 Mar-Apr;20(2):92-100.

PMID:
12836809
19.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406

Supplemental Content

Support Center